WALTHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle illness firm targeted on advancing revolutionary life-transforming therapeutics for folks dwelling with genetically pushed ailments, at this time introduced that administration is scheduled to take part in a fireplace chat at the Morgan Stanley 20th Annual Global Healthcare Conference being held in New York, NY on Monday, September 12, 2022 at 2:15 p.m. ET.
A stay webcast will probably be out there within the Investors & Media part of Dyne’s web site at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will probably be accessible for 90 days following the presentation.
About Dyne Therapeutics
Dyne Therapeutics is a clinical-stage muscle illness firm targeted on advancing revolutionary life-transforming therapeutics for folks dwelling with genetically pushed ailments. With its proprietary FORCE™ platform, Dyne is creating trendy oligonucleotide therapeutics which might be designed to overcome limitations in supply to muscle tissue seen with different approaches. Dyne has a broad portfolio of applications for critical muscle ailments, together with candidates for myotonic dystrophy kind 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). For extra info, please go to https://www.dyne-tx.com/, and observe us on Twitter, LinkedIn and Facebook.
Contact:
Dyne Therapeutics
Amy Reilly
[email protected]
857-341-1203
